FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for alendronate sodium filed by Aurobindo Pharma Limited (ANDA 090124).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)